All terms in DRUGBANK

Label Id Description
Squaric acid dibutyl ester DB12223 [Squaric acid dibutyl ester is under investigation in clinical trial NCT01971385 (Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis).]
Moperone DB13554
BIO-11006 DB14886 [BIO-11006 is under investigation in clinical trial NCT03202394 (Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS).]
PF-05180999 DB14885 [PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999).]
Prajmaline DB13555
Oxothiazolidinecarboxylic acid DB12224 [Procysteine has been used in trials studying the treatment of HIV Infections.]
IQP-0528 DB14888 [IQP-0528 is under investigation in clinical trial NCT03082690 (ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study).]
Sulfamazone DB13556
Beclabuvir DB12225 [Beclabuvir has been used in trials studying the treatment of Hepatitis C, Chronic.]
Thiopropazate DB13557
Terameprocol DB12226 [Terameprocol has been investigated for the treatment of Brain and Central Nervous System Tumors.]
PF-04620110 DB14887 [PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).]
Bifemelane DB13550
CEP-9722 DB14882 [CEP-9722 is under investigation in clinical trial NCT01345357 (Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma).]
Oliceridine DB14881 [Oliceridine is under investigation in clinical trial NCT02820324 (Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty).]
ORG-25935 DB12220 [Org 25935 has been used in trials studying the treatment of Alcoholism, Schizophrenia, and Panic Disorder.]
Cinchophen DB13551
Imgatuzumab DB14884 [Imgatuzumab is under investigation in clinical trial NCT01326000 (A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer).]
Trifluperidol DB13552
Canrenone DB12221 [Canrenone has been used in trials studying the diagnostic of Heart Failure.]